Workers in the coking, foundry, and aluminum industry can be exposed to high concentrations of polycyclic aromatic hydrocarbons (PAHs) and are at increased risk for lung cancer, as are cigarette smokers. In recent years several studies on workers in the foundry andcoking industries have been reported. In these studies, white blood cell (WBC) DNA was used for analysis of PAH-DNA adducts. Theoretically, DNA adduct formation is a more relevant biological parameter for assessing exposure risk than PAH in the work atmosphere, or the amount ofa metabolite in the urine, because adduct levels reflect that part of the dose that escapes detoxification and binds to DNA. We analyzed WBC DNA from coke-oven workers and from workers in an aluminum production plant and demonstrated the presence ofPAH-DNA adducts. Fortyseven percent ofthe coke-oven workers had detectable levels of PAH-DNA adducts in their WBC compared with 27% of the controls (p < (LO), measured with ELISA. In both groups, smokers hadsigificantly higherlevelsofPAH-DNAadducts than did nonsmokers. In the aluminum workers, no PAH-DNA adducts were detected by ELISA, although the benzo[aJpyrene concentrations in the work atmosphere were comparable to those of the coke-oven workers. The more sensitive 32P-postlabeling assay showed the presence of PAH-DNA adducts in 91% of the aluminum workers. There was no correlation of WBC adduct levels with the concentration ofPAH in the work atmosphere. Recently we showed that total PAH-DNA adduct levels in WBC from lung cancer patients were much higher than those generally found in healthy smokers. These increased adduct levels may indicate a subpopulation of smokers with increased risk for lung cancer, resulting from a genetic predisposition in this group of persons. Because WBCs are not the target cells for exposure-related cancer, the relationship between PAH-DNA adducts in the lung and in WBCs remains to be established.
Introduction
A large number of chemical carcinogens, such as polycyclic aromatic hydrocarbons (PAHs), react covalently with DNA and may thereby initiate the multistage process leading to malignancy (1) . These DNA adducts may serve as quantitative indicators of biologically effective doses of specific carcinogens. Advances in analytical methods during the last decade make possible the sensitive measurement ofcovalent adducts ofcarcinogens with DNA in humans (2) . Methods of PAH-DNA adduct analysis involve immunochemical assays (3, 4) , synchronous fluorescence spectroscopy (SFS) (5) , and postlabeling of adducted deoxyribonucleotides with [32P]phosphate (6, 7) . The 32P-postlabeling analysis is the most sensitive method, and the high specific radioactivity of [32P]ATP used in this procedure allows detection of 1 adduct in 109 bases (7) . However, resolution of individual PAH-DNA adducts from complex mixtures by TLC is often difficult, and several methods have been developed to improve the resolution ofthe 32P-labeled adducted nucleotides. HPLC seems to be the most promising approach to optimize the detection of multiple adducts in one DNA sample (8, 9) . In addition to better separation of adducted nucleotides, the HPLC method also facilitates the identification of individual DNA adducts by mass spectrometry.
Immunochemical methods, i.e., immunoassays of adducted DNA or nucleotides and immunocytochemistry of tissues and cells, employ antibodies that are raised against carcinogenmodified DNA or nucleosides or nucleotides (3, 4) . Immu 
Aluminum Production
Relatively few studies have been reported on PAH-DNA adduct levels in workers from aluminum production plants (5, 18 ). An extensive occupational study in an aluminum production plant is being performed at present in our laboratory. A typical PAH profile of the personal air samples is shown in Figure IB , which shows that in this industry pyrene is the most abundant PAH. The observed difference between PAH profiles ofthe coke ovens and aluminum production plant emphasizes the importance of obtaining data on the actual PAH levels present in the surrounding air ofthe workers. Surprisingly, no PAH-DNA adducts in the WBCs ofthese workers could be detected by ELISA with our anti-benzo[a]pyrene diolepoxide (BPDE)-DNA antibody, although the absolute concentration of BaP did not differ much from that at the coke ovens. Apparently, exposure to results from different laboratories should be done with caution. Unfortunately, interlaboratory standardization of the methodology has not yet been realized, despite the fact that both immunoassays and the 32P-postlabeling analysis have now been used for a period of 10 years. For example, the quantification of DNA adducts by ELISA depends on several factors, including modification level of standard DNA, characteristics of the particular antibody used, the type of assay, and the end point used. Underestimation ofadducts in DNA from biological samples has been observed by us and other investigators using anti BPDE-DNA antisera and serially dilutions ofhighly modified BPDE-DNA as standards (19, 20) . Appropriate DNA preparations of low modification level, obtained from experimental animals treated with a specific PAH, are required as reference material when human DNA samples are to be analyzed.
Similar uncertainties are encountered in the quantification of adducts by the 32P-postlabeling analysis. The postlabeling procedure is based on the relative resistance ofthe PAH-modified nucleotides to 3 '-dephosphorylation by nuclease P1. However, various carcinogen-DNA adducts differ in their susceptibility to nuclease P1 (21) . The micrococcal nuclease/spleen phosphodiesterase digestion used in the original 32P-postlabeling procedure developed by Randerath 
Sensitivity, Reproducibility, and Applicability
The high level ofsensitivity ofthe 32P-postlabeling assay with a lower detection limit of 1 adduct in 109 nucleotides is essential to measure adduct levels occurring in human DNA samples. The detection limit ofthe immunocytochemical detection we use is 7 BPDE-DNA adducts in 108 nucleotides. This method, with the aid ofnew quantification techniques (laser-scan microscopy), has promise for the measurement ofadducts in human cells or tissues. Izzotti etal. (27) found PAH-DNAadductlevelsof 1 adduct in 107 nucleotides in alveolar macrophages ofsmokers, levels that seem sufficient to be detected in individual cells by immunocytochemical methods. In summary, adduct-specific antibodies are quite useful in various specific applications, i.e., immunocytochemistry and enzyme immunoassays. As pointed out already, further standardization and validation oftechniques is urgently needed to avoid systemic errors in measurements before these methods can be applied to large-scale epidemiological studies.
